1999
DOI: 10.1006/cimm.1999.1589
|View full text |Cite
|
Sign up to set email alerts
|

Identification of IFN-γ-Producing Cells in IL-12/IL-18-Treated Mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
60
0

Year Published

2004
2004
2019
2019

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 77 publications
(63 citation statements)
references
References 26 publications
3
60
0
Order By: Relevance
“…NKT cell subpopulations may be double-negative, single-positive or double-positive with regards to CD4 and CD8 molecule expression [4,6,[7][8][9]. Recently, the involvement of NKT cells in modulating immune responses to various antigens has been implicated [7,[10][11][12][13][14][15][16][17][18][19]. They have been found to be essential in tumor rejection as well as in the prevention of autoimmune diseases, such as multiple sclerosis and chronic inflammatory demyelinating polyneuropathy [12][13][14].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…NKT cell subpopulations may be double-negative, single-positive or double-positive with regards to CD4 and CD8 molecule expression [4,6,[7][8][9]. Recently, the involvement of NKT cells in modulating immune responses to various antigens has been implicated [7,[10][11][12][13][14][15][16][17][18][19]. They have been found to be essential in tumor rejection as well as in the prevention of autoimmune diseases, such as multiple sclerosis and chronic inflammatory demyelinating polyneuropathy [12][13][14].…”
Section: Introductionmentioning
confidence: 99%
“…The mechanism underlying the initiation and development of allergic responses remains unclear. Due to the fact that NKT cells are capable of rapidly secreting key immunoregulatory cytokines such as IL-4 and IFN-+ [10,11], they are likely to play a role in modulating allergic diseases. However, comprehensive studies are lacking regarding the role of NKT cells and CD1 molecules in allergic responses especially in asthmatic reactions.…”
Section: Introductionmentioning
confidence: 99%
“…48 The ELISA results showed that the mice from rClone30-IL-12-IL-2 treatment group induced more IFN-g and IP-10 released, both of these molecules have been shown to be antiangiogenestic, which might be another important factor for resulting in inhibition of tumor growth. [25][26][27][28] The high expression level of the inserted genes within tumor and negligible in serum highlight the safety and efficiency of NDV serve as a vector for delivering human IL-12 and IL-2 into tumor cells in the future application. At the end of this study, virus-treated mice were rechallenged with the same tumor cells, and results showed that viral-treated mice were efficiently protected from rechallenged.…”
Section: Discussionmentioning
confidence: 99%
“…25,26 Extensive research suggested that IL-12 promotes an effective destruction of cancer cells by inducing proliferation of NK cells and T cells and production of IFN-g, and IL-12 enhances the generation and activity of cytotoxic T lymphocytes (CTLs) through activation of STAT4. [27][28][29][30] It is important to note that IFN-g is able to induce a powerful protection against the development of tumors by inducing the production of interferon-g-induced protein 10 (IP-10) and monokine induced by gamma-interferon (MIG), which promote antiangiogenic activity. In addition, several other mechanisms of IL-12 strongly contribute to antitumor activities.…”
Section: Introductionmentioning
confidence: 99%
“…Studies have reported that IL-12 as a cytokine has antitumor therapeutic activities, and it has been shown to inhibit tumorigenesis and induce regression of established tumors. IL-12 promotes the effective destruction of cancer cells by inducing proliferation of NK and T cells, and IL-12 enhances the generation and activity of cytotoxic T lymphocytes (CTLs) (18,19). In addition, several other mechanisms of IL-12 strongly contribute to antitumor activities (20,21), and the antitumor activity of IL-12 can be improved by its combination with various therapeutics (22,23).…”
Section: Introductionmentioning
confidence: 99%